Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neogenomics Inc (NQ: NEO )

17.98 +0.33 (+1.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 754,877
Open 17.95
Bid (Size) 16.96 (1)
Ask (Size) 18.17 (3)
Prev. Close 17.65
Today's Range 17.60 - 18.15
52wk Range 6.000 - 20.54
Shares Outstanding 122,816,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
Via ACCESSWIRE
NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO
Via ACCESSWIRE

Performance

YTD
+97.80%
+97.80%
1 Month
+24.43%
+24.43%
3 Month
+2.68%
+2.68%
6 Month
+52.37%
+52.37%
1 Year
+122.80%
+122.80%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
Via Benzinga
NeoGenomics's Return On Capital Employed Insights
Via Benzinga
Earnings Scheduled For May 12, 2023
Via Benzinga
NeoGenomics: Q1 Earnings Insights
Via Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
NeoGenomics Reports Q1 Topline Growth, Lifts Annual Guidance, Shares Soar
Via Benzinga
Analyst Expectations for NeoGenomics's Future
Via Benzinga
NeoGenomics Reports First Quarter 2023 Results
Via ACCESSWIRE
What 9 Analyst Ratings Have To Say About NeoGenomics
Via Benzinga
Looking Into NeoGenomics's Return On Capital Employed
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
Via Benzinga
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
NeoGenomics to Participate at the BofA Securities 2023 Healthcare Conference
Via ACCESSWIRE
Analyst Ratings for NeoGenomics
Via Benzinga
NeoGenomics, Inc. (NASDAQ:NEO) Long Term Investor Alert: Investigation of Potential Wrongdoing
Via SBWire
NeoGenomics to Announce First Quarter 2023 Financial Results
Via ACCESSWIRE
NeoGenomics to Participate at the 22nd Annual Needham Virtual Healthcare Conference
Via ACCESSWIRE
NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023
Via ACCESSWIRE
NeoGenomics to Host Investor Day on April 4, 2023
Via ACCESSWIRE
Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care
From Massive Bio, Inc.
Via Business Wire
3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing
Via The Motley Fool
NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test
Via ACCESSWIRE
NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.